If you are a medical device manufacturer interested in the alternative entry pathways into Chinese market, you are cordially invited to join the third webinar of the Cisema Webinar Series.
In the first webinar of the series, on March 4, 2021, we were delighted to share a basic understanding of the medical device registration process in China and have an interactive session with our participants.
In our second webinar, on June 8, 2021, our Cisema experts informed you about the latest regulatory changes in China, including Order 739, device lifetime, UDI, MAH system, and real-world data.
If you missed either webinar, feel free to let us know if you are interested to watch the replay. Watching the replays will equip you with a basic understanding of the registration process and recent hot topics.
In the upcoming third webinar of the series, our Cisema experts will be informing you about alternative entry pathways to China. Details as follows:
Wednesday, September 15, 2021 – 10:00 CET – Alternative Entry Pathways to China
- Fast-track channels (priority, innovation, emergency approval)
- Hong Kong listing
- Greater Bay Area
- Hainan Pilot Zone system
Register here to keep up with the fast changing regulatory environment in China.
In the final webinar of the year, you can expect topics such as PMS (post-market surveillance), QMS (quality management system), and software and its regulatory implications in China. So make sure you don’t miss it on Thursday, December 2, 2021 – 10:00 CET.
You are encouraged to ask questions in our live webinars. Should you be in a different time zone, you are invited to register for the webinar series and watch the replay any time.
Contact Cisema if you have any questions.
